TYRATECH • ANNUAL REPORT 2014 • PAGE 27
C o n s o l i d at e d S t at e m e n t s o f C a s h Fl o w s
Ye a rs E n d e d D e c e m b e r 3 1 , 2 0 1 4 & 2 0 1 3 i n $ 0 0 0 's
2014 2013
Cash flows from operating activities:
Net loss $(5,094) $(4,902)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation 96 109
Amortisation of stock awards 152 161
Change in fair value of warrant liability (187) 210
Net loss from unconsolidated subsidiary 300 359
Changes in operating assets and liabilities:
Accounts receivable (824) 25
Inventory (862) (46)
Prepaid expenses and long-term deposits (45) (69)
Accounts payable and accrued liabilities 973 18
Deferred revenue and other long-term liabilities (1,721) (501)
Net cash used in operating activities (7,212) (4,636)
Cash flows from investing activities:
Purchases of property and equipment (12) (18)
Investment in unconsolidated subsidiary (300) -
Net cash used in investing activities (312) (18)
Cash flows from financing activities:
Net proceeds from sale of common stock 8,150 3,978
Equity warrants issued 210 -
Exercise of SARS 1 -
Exercise of warrants 500 -
Net cash provided by financing activities 8,861 3,978
Net increase (decrease) in cash 1,337 (676)
Cash and cash equivalents, beginning of year 873 1,549
Accumulated other comprehensive income 2 -
Cash and cash equivalents, end of year $2,212 $873
The accompanying notes are an integral part of these consolidated financial statements.
